China Universal Asset Management »

Eliem Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 12k 2.01
2025-06-30 $17k 14k 1.24
2025-03-31 $17k 14k 1.22
2024-12-31 $26k 14k 1.80

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Eliem Therapeutics

RA Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Tang Capital Management
BlackRock
Peapod Lane Capital
Cantor Fitzgerald, L. P.
Renaissance Technologies
Deep Track Capital
Alyeska Investment Group
Millennium Management
Nan Fung Trinity
Sphera Funds Management
UBS Group

View all funds holding Eliem Therapeutics